Repligen Corporation
RGEN
$111.49
$1.371.24%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 18.12% | 21.91% | 14.81% | 10.44% | 0.56% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.12% | 21.91% | 14.81% | 10.44% | 0.56% |
| Cost of Revenue | 7.85% | 16.33% | 16.37% | 2.60% | 8.42% |
| Gross Profit | 29.28% | 27.28% | 13.35% | 18.13% | -6.79% |
| SG&A Expenses | 96.09% | -0.38% | 6.28% | 14.24% | -33.70% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 32.69% | 10.39% | 13.35% | 7.91% | -7.46% |
| Operating Income | -46.77% | 370.88% | 49.34% | 82.70% | 63.74% |
| Income Before Tax | 149.51% | 1,589.30% | 101.78% | 114.97% | -2,170.13% |
| Income Tax Expenses | 222.94% | 544.65% | 1.06% | 429.57% | -125.87% |
| Earnings from Continuing Operations | 139.23% | 2,379.97% | 160.21% | 76.88% | -105.89% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 139.23% | 2,379.97% | 160.21% | 76.88% | -105.89% |
| EBIT | -46.77% | 370.88% | 49.34% | 82.70% | 63.74% |
| EBITDA | -26.04% | 156.90% | 26.73% | 27.61% | 36.26% |
| EPS Basic | 139.06% | 2,364.96% | 158.71% | 75.80% | -105.02% |
| Normalized Basic EPS | -38.76% | 630.96% | 38.55% | 110.12% | 21.58% |
| EPS Diluted | 137.74% | 2,322.22% | 160.00% | 69.20% | -106.89% |
| Normalized Diluted EPS | -39.13% | 627.41% | 39.30% | 111.13% | 21.58% |
| Average Basic Shares Outstanding | 0.45% | 0.45% | 0.63% | 0.60% | 0.43% |
| Average Diluted Shares Outstanding | 1.07% | 0.93% | 0.13% | 0.05% | 0.43% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |